instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'CARMUSTINE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 300 MILLIGRAM/SQ. METER, DAY 6 | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the dosage of drug 'CYTARABINE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 200 MILLIGRAM/SQ. METER, FOR 4 DAYS | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the dosage of drug 'DACARBAZINE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 400 MILLIGRAM/SQ. METER, DAYS 1 AND 15 | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the dosage of drug 'DOXORUBICIN'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 25 MILLIGRAM/SQ. METER, DAYS 1 AND 15 | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the dosage of drug 'ETOPOSIDE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 100 MILLIGRAM/SQ. METER, FOR 4 DAYS | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the dosage of drug 'FLUDARABINE PHOSPHATE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 30 MILLIGRAM/SQ. METER, FOR 3 DAYS | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the dosage of drug 'MELPHALAN'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 160 MILLIGRAM/SQ. METER FOR 1 DAY | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the dosage of drug 'PREDNISONE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 1 MILLIGRAM/KG FOR 10 DAYS | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the dosage of drug 'PROCARBAZINE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 100 MILLIGRAM/SQ. METER, DAILY | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the dosage of drug 'THIOTEPA'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 7 MILLIGRAM/SQ. METER, FOR 1 DAY | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the dosage of drug 'VINBLASTINE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 6 MILLIGRAM/SQ. METER, DAYS 1 AND 15 | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the dosage of drug 'VINCRISTINE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 1.5 MILLIGRAM/SQ. METER, DAYS 1 AND 8 | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute graft versus host disease in intestine'. | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | BLINATUMOMAB | DrugsGivenReaction | CC BY-NC | 33747421 | 19,012,494 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute graft versus host disease in skin'. | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | BLINATUMOMAB | DrugsGivenReaction | CC BY-NC | 33747421 | 19,012,494 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic graft versus host disease in eye'. | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | BLINATUMOMAB | DrugsGivenReaction | CC BY-NC | 33747421 | 19,012,494 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic graft versus host disease in skin'. | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | BLINATUMOMAB | DrugsGivenReaction | CC BY-NC | 33747421 | 19,012,494 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | BLINATUMOMAB | DrugsGivenReaction | CC BY-NC | 33747421 | 19,012,494 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Graft versus host disease in gastrointestinal tract'. | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | BENDAMUSTINE, BLINATUMOMAB, BRENTUXIMAB VEDOTIN, BUSULFAN, CISPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, FLUDARABINE PHOSPHATE, GEMCITABINE, MELPHALAN, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33747421 | 19,261,748 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Graft versus host disease in lung'. | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | BLINATUMOMAB | DrugsGivenReaction | CC BY-NC | 33747421 | 19,012,494 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Graft versus host disease in skin'. | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | BENDAMUSTINE, BLINATUMOMAB, BRENTUXIMAB VEDOTIN, BUSULFAN, CISPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, FLUDARABINE PHOSPHATE, GEMCITABINE, MELPHALAN, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33747421 | 19,261,748 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | BLINATUMOMAB | DrugsGivenReaction | CC BY-NC | 33747421 | 19,012,494 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Primary mediastinal large B-cell lymphoma recurrent'. | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | BLINATUMOMAB | DrugsGivenReaction | CC BY-NC | 33747421 | 19,012,494 | 2021 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | UNKNOWN | DrugDosageText | CC BY-NC | 33747421 | 19,103,583 | 2021 |
What was the dosage of drug 'CYCLOSPORINE'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | UNKNOWN | DrugDosageText | CC BY-NC | 33747421 | 19,103,583 | 2021 |
What was the dosage of drug 'DOXORUBICIN'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | UNKNOWN | DrugDosageText | CC BY-NC | 33747421 | 19,103,583 | 2021 |
What was the dosage of drug 'ETOPOSIDE'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | UNKNOWN | DrugDosageText | CC BY-NC | 33747421 | 19,103,583 | 2021 |
What was the dosage of drug 'PREDNISONE'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | UNKNOWN | DrugDosageText | CC BY-NC | 33747421 | 19,103,583 | 2021 |
What was the dosage of drug 'RITUXIMAB'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | UNKNOWN | DrugDosageText | CC BY-NC | 33747421 | 19,103,583 | 2021 |
What was the dosage of drug 'RUXOLITINIB'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | UNKNOWN | DrugDosageText | CC BY-NC | 33747421 | 19,103,583 | 2021 |
What was the dosage of drug 'TACROLIMUS'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | STARTED ON DAY PLUS 33 WITH DISCONTINUATION ON DAY PLUS 40. | DrugDosageText | CC BY-NC | 33747421 | 19,260,660 | 2021 |
What was the dosage of drug 'VINCRISTINE'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | UNKNOWN | DrugDosageText | CC BY-NC | 33747421 | 19,103,583 | 2021 |
What was the outcome of reaction 'Acute graft versus host disease in intestine'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | Recovering | ReactionOutcome | CC BY-NC | 33747421 | 19,012,494 | 2021 |
What was the outcome of reaction 'Acute graft versus host disease in skin'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | Recovering | ReactionOutcome | CC BY-NC | 33747421 | 19,012,494 | 2021 |
What was the outcome of reaction 'Chronic graft versus host disease in eye'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | Recovering | ReactionOutcome | CC BY-NC | 33747421 | 19,012,494 | 2021 |
What was the outcome of reaction 'Chronic graft versus host disease in skin'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | Recovering | ReactionOutcome | CC BY-NC | 33747421 | 19,012,494 | 2021 |
What was the outcome of reaction 'Graft versus host disease in gastrointestinal tract'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | Recovered | ReactionOutcome | CC BY-NC | 33747421 | 19,261,748 | 2021 |
What was the outcome of reaction 'Graft versus host disease in lung'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | Recovering | ReactionOutcome | CC BY-NC | 33747421 | 19,012,494 | 2021 |
What was the outcome of reaction 'Graft versus host disease in skin'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | Not recovered | ReactionOutcome | CC BY-NC | 33747421 | 19,261,748 | 2021 |
What was the outcome of reaction 'Hypoalbuminaemia'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | Recovered | ReactionOutcome | CC BY-NC | 33747421 | 19,012,494 | 2021 |
What was the outcome of reaction 'Pancytopenia'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | Recovered | ReactionOutcome | CC BY-NC | 33747421 | 19,012,494 | 2021 |
What was the outcome of reaction 'Primary mediastinal large B-cell lymphoma recurrent'? | Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare hematologic malignancy with distinct clinical and immunopathological features. We report a case of a young male with d... | Recovered | ReactionOutcome | CC BY-NC | 33747421 | 19,012,494 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | BUPIVACAINE, EPINEPHRINE, FENTANYL, FUROSEMIDE, HYDROMORPHONE, MAGNESIUM SULFATE, NITROGLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, ROCURONIUM BROMIDE, SEVOFLURANE, SUGAMMADEX, VECURONIUM BROMIDE | DrugsGivenReaction | CC BY | 33747571 | 19,115,030 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | BUPIVACAINE, EPINEPHRINE, FENTANYL, FUROSEMIDE, HYDROMORPHONE, MAGNESIUM SULFATE, NITROGLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, ROCURONIUM BROMIDE, SEVOFLURANE, SUGAMMADEX, VECURONIUM BROMIDE | DrugsGivenReaction | CC BY | 33747571 | 19,115,030 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rales'. | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | BUPIVACAINE, EPINEPHRINE, FENTANYL, FUROSEMIDE, HYDROMORPHONE, MAGNESIUM SULFATE, NITROGLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, ROCURONIUM BROMIDE, SEVOFLURANE, SUGAMMADEX, VECURONIUM BROMIDE | DrugsGivenReaction | CC BY | 33747571 | 19,115,030 | 2021 |
What is the weight of the patient? | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | 90.7 kg. | Weight | CC BY | 33747571 | 19,123,002 | 2021 |
What was the administration route of drug 'BUPIVACAINE'? | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | Epidural | DrugAdministrationRoute | CC BY | 33747571 | 19,123,002 | 2021 |
What was the administration route of drug 'FENTANYL'? | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | Intramuscular | DrugAdministrationRoute | CC BY | 33747571 | 19,115,030 | 2021 |
What was the administration route of drug 'HYDROMORPHONE'? | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | Epidural | DrugAdministrationRoute | CC BY | 33747571 | 19,123,002 | 2021 |
What was the administration route of drug 'MAGNESIUM SULFATE'? | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33747571 | 19,123,002 | 2021 |
What was the administration route of drug 'PHENYLEPHRINE HYDROCHLORIDE'? | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33747571 | 19,123,002 | 2021 |
What was the administration route of drug 'VECURONIUM BROMIDE'? | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | Intramuscular | DrugAdministrationRoute | CC BY | 33747571 | 19,115,030 | 2021 |
What was the dosage of drug 'EPINEPHRINE'? | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | 0.05 UG/KG, QMN | DrugDosageText | CC BY | 33747571 | 19,115,030 | 2021 |
What was the dosage of drug 'HYDROMORPHONE'? | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | SOLUTION; | DrugDosageText | CC BY | 33747571 | 19,115,030 | 2021 |
What was the dosage of drug 'SEVOFLURANE'? | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | 3.3?4% END?TIDAL CONCENTRATION; | DrugDosageText | CC BY | 33747571 | 19,115,030 | 2021 |
What was the dosage of drug 'UNSPECIFIED INGREDIENT'? | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | 900 ML | DrugDosageText | CC BY | 33747571 | 19,123,002 | 2021 |
What was the outcome of reaction 'Dyspnoea'? | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | Recovered | ReactionOutcome | CC BY | 33747571 | 19,115,030 | 2021 |
What was the outcome of reaction 'Pulmonary oedema'? | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | Recovered | ReactionOutcome | CC BY | 33747571 | 19,123,002 | 2021 |
What was the outcome of reaction 'Rales'? | Successful Anesthesia Management of Postoperative Maternal Pulmonary Edema and Uterine Hyperactivity following Open Fetal Myelomeningocele Repair.
Effective tocolysis is essential after fetal myelomeningocele repair and is associated with the development of pulmonary edema. The increased uterine activity in the immedia... | Recovered | ReactionOutcome | CC BY | 33747571 | 19,115,030 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Histiocytic sarcoma'. | A Rare Case of Histiocytic Sarcoma Secondary to Gastrointestinal Stromal Tumor in the Stomach: Transdifferentiation or Synchronicity?
Histiocytic sarcoma is a rare malignant histiocytic neoplasm composed of cells with morphologic and immunophenotypic features of mature tissue histiocytes. It occurs anywhere in the body... | IMATINIB MESYLATE | DrugsGivenReaction | CC BY | 33747577 | 19,177,055 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | The Effects of Voriconazole on Metabolism of All-Trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia: A Case Report.
All-trans retinoic acid (ATRA) is a derivative of vitamin A and is the mainstay treatment of acute promyelocytic leukemia (APL). Hypercalcemia is a rare yet important side-effect of ATRA... | ARSENIC, DAUNORUBICIN, MEROPENEM, OMEPRAZOLE, TRETINOIN, VANCOMYCIN, VORICONAZOLE | DrugsGivenReaction | CC BY | 33747646 | 19,098,148 | 2021-02-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypercalcaemia'. | The Effects of Voriconazole on Metabolism of All-Trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia: A Case Report.
All-trans retinoic acid (ATRA) is a derivative of vitamin A and is the mainstay treatment of acute promyelocytic leukemia (APL). Hypercalcemia is a rare yet important side-effect of ATRA... | ARSENIC, DAUNORUBICIN, MEROPENEM, OMEPRAZOLE, TRETINOIN, VANCOMYCIN, VORICONAZOLE | DrugsGivenReaction | CC BY | 33747646 | 19,098,148 | 2021-02-14 |
What was the administration route of drug 'VORICONAZOLE'? | The Effects of Voriconazole on Metabolism of All-Trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia: A Case Report.
All-trans retinoic acid (ATRA) is a derivative of vitamin A and is the mainstay treatment of acute promyelocytic leukemia (APL). Hypercalcemia is a rare yet important side-effect of ATRA... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33747646 | 19,098,148 | 2021-02-14 |
What was the dosage of drug 'ARSENIC'? | The Effects of Voriconazole on Metabolism of All-Trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia: A Case Report.
All-trans retinoic acid (ATRA) is a derivative of vitamin A and is the mainstay treatment of acute promyelocytic leukemia (APL). Hypercalcemia is a rare yet important side-effect of ATRA... | DAY ONE | DrugDosageText | CC BY | 33747646 | 19,098,148 | 2021-02-14 |
What was the dosage of drug 'DAUNORUBICIN'? | The Effects of Voriconazole on Metabolism of All-Trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia: A Case Report.
All-trans retinoic acid (ATRA) is a derivative of vitamin A and is the mainstay treatment of acute promyelocytic leukemia (APL). Hypercalcemia is a rare yet important side-effect of ATRA... | DAY ONE | DrugDosageText | CC BY | 33747646 | 19,098,148 | 2021-02-14 |
What was the dosage of drug 'TRETINOIN'? | The Effects of Voriconazole on Metabolism of All-Trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia: A Case Report.
All-trans retinoic acid (ATRA) is a derivative of vitamin A and is the mainstay treatment of acute promyelocytic leukemia (APL). Hypercalcemia is a rare yet important side-effect of ATRA... | DAY ONE, STOPPED ON THE 15TH DAY, RESUMED | DrugDosageText | CC BY | 33747646 | 19,098,148 | 2021-02-14 |
What was the outcome of reaction 'Hypercalcaemia'? | The Effects of Voriconazole on Metabolism of All-Trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia: A Case Report.
All-trans retinoic acid (ATRA) is a derivative of vitamin A and is the mainstay treatment of acute promyelocytic leukemia (APL). Hypercalcemia is a rare yet important side-effect of ATRA... | Recovered | ReactionOutcome | CC BY | 33747646 | 19,098,148 | 2021-02-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis.
We describe a fatal case of diffuse alveolar hemorrhage (DAH) complicated by rheumatoid arthritis (RA). A female patient was diagnosed with RA two months earlier and was treated with prednisolone and tacrolimus due to abnormalities in ches... | HUMAN IMMUNOGLOBULIN G, LEVOFLOXACIN, METHYLPREDNISOLONE, SIVELESTAT | DrugsGivenReaction | CC BY-NC-ND | 33747760 | 19,110,986 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diffuse alveolar damage'. | A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis.
We describe a fatal case of diffuse alveolar hemorrhage (DAH) complicated by rheumatoid arthritis (RA). A female patient was diagnosed with RA two months earlier and was treated with prednisolone and tacrolimus due to abnormalities in ches... | HUMAN IMMUNOGLOBULIN G, LEVOFLOXACIN, METHYLPREDNISOLONE, SIVELESTAT | DrugsGivenReaction | CC BY-NC-ND | 33747760 | 19,110,986 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis.
We describe a fatal case of diffuse alveolar hemorrhage (DAH) complicated by rheumatoid arthritis (RA). A female patient was diagnosed with RA two months earlier and was treated with prednisolone and tacrolimus due to abnormalities in ches... | HUMAN IMMUNOGLOBULIN G, LEVOFLOXACIN, METHYLPREDNISOLONE, SIVELESTAT | DrugsGivenReaction | CC BY-NC-ND | 33747760 | 19,110,986 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemoptysis'. | A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis.
We describe a fatal case of diffuse alveolar hemorrhage (DAH) complicated by rheumatoid arthritis (RA). A female patient was diagnosed with RA two months earlier and was treated with prednisolone and tacrolimus due to abnormalities in ches... | HUMAN IMMUNOGLOBULIN G, LEVOFLOXACIN, METHYLPREDNISOLONE, SIVELESTAT | DrugsGivenReaction | CC BY-NC-ND | 33747760 | 19,110,986 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Organising pneumonia'. | A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis.
We describe a fatal case of diffuse alveolar hemorrhage (DAH) complicated by rheumatoid arthritis (RA). A female patient was diagnosed with RA two months earlier and was treated with prednisolone and tacrolimus due to abnormalities in ches... | EDOXABAN TOSYLATE, FUROSEMIDE, PREDNISOLONE, SPIRONOLACTONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 33747760 | 19,679,029 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary alveolar haemorrhage'. | A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis.
We describe a fatal case of diffuse alveolar hemorrhage (DAH) complicated by rheumatoid arthritis (RA). A female patient was diagnosed with RA two months earlier and was treated with prednisolone and tacrolimus due to abnormalities in ches... | EDOXABAN TOSYLATE, FUROSEMIDE, PREDNISOLONE, SPIRONOLACTONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 33747760 | 19,679,029 | 2021 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis.
We describe a fatal case of diffuse alveolar hemorrhage (DAH) complicated by rheumatoid arthritis (RA). A female patient was diagnosed with RA two months earlier and was treated with prednisolone and tacrolimus due to abnormalities in ches... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33747760 | 19,110,986 | 2021 |
What was the outcome of reaction 'Diffuse alveolar damage'? | A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis.
We describe a fatal case of diffuse alveolar hemorrhage (DAH) complicated by rheumatoid arthritis (RA). A female patient was diagnosed with RA two months earlier and was treated with prednisolone and tacrolimus due to abnormalities in ches... | Fatal | ReactionOutcome | CC BY-NC-ND | 33747760 | 19,110,986 | 2021 |
What was the outcome of reaction 'Disease progression'? | A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis.
We describe a fatal case of diffuse alveolar hemorrhage (DAH) complicated by rheumatoid arthritis (RA). A female patient was diagnosed with RA two months earlier and was treated with prednisolone and tacrolimus due to abnormalities in ches... | Fatal | ReactionOutcome | CC BY-NC-ND | 33747760 | 19,110,986 | 2021 |
What was the outcome of reaction 'Drug ineffective'? | A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis.
We describe a fatal case of diffuse alveolar hemorrhage (DAH) complicated by rheumatoid arthritis (RA). A female patient was diagnosed with RA two months earlier and was treated with prednisolone and tacrolimus due to abnormalities in ches... | Fatal | ReactionOutcome | CC BY-NC-ND | 33747760 | 19,072,728 | 2021 |
What was the outcome of reaction 'Interstitial lung disease'? | A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis.
We describe a fatal case of diffuse alveolar hemorrhage (DAH) complicated by rheumatoid arthritis (RA). A female patient was diagnosed with RA two months earlier and was treated with prednisolone and tacrolimus due to abnormalities in ches... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33747760 | 19,679,029 | 2021 |
What was the outcome of reaction 'Pulmonary alveolar haemorrhage'? | A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis.
We describe a fatal case of diffuse alveolar hemorrhage (DAH) complicated by rheumatoid arthritis (RA). A female patient was diagnosed with RA two months earlier and was treated with prednisolone and tacrolimus due to abnormalities in ches... | Fatal | ReactionOutcome | CC BY-NC-ND | 33747760 | 19,679,029 | 2021 |
What was the outcome of reaction 'Respiratory failure'? | A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis.
We describe a fatal case of diffuse alveolar hemorrhage (DAH) complicated by rheumatoid arthritis (RA). A female patient was diagnosed with RA two months earlier and was treated with prednisolone and tacrolimus due to abnormalities in ches... | Fatal | ReactionOutcome | CC BY-NC-ND | 33747760 | 19,110,986 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease.
Necrotizing autoimmune myopathy (NAM) is a rare inflammatory process characterized by bilateral proximal muscle weakness and elevated creatinine kinase levels. It is one of the idiopathic inflammatory myopathies. It can be ass... | MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 33747761 | 19,248,529 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Interstitial lung disease'. | Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease.
Necrotizing autoimmune myopathy (NAM) is a rare inflammatory process characterized by bilateral proximal muscle weakness and elevated creatinine kinase levels. It is one of the idiopathic inflammatory myopathies. It can be ass... | MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 33747761 | 19,248,529 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease.
Necrotizing autoimmune myopathy (NAM) is a rare inflammatory process characterized by bilateral proximal muscle weakness and elevated creatinine kinase levels. It is one of the idiopathic inflammatory myopathies. It can be ass... | AMBRISENTAN, MYCOPHENOLATE MOFETIL, PREDNISONE, TADALAFIL | DrugsGivenReaction | CC BY-NC-ND | 33747761 | 19,645,464 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteonecrosis'. | Unexpected long-term survival in an adult patient with metastatic prostate cancer.
According to statistics, the 5-year overall survival in metastatic prostate cancer is about 21 months. We present a case of a patient with castration-resistant prostate cancer with proven bone lesions 2 years after the onset of the disea... | CYPROTERONE ACETATE, STRONTIUM, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33747795 | 19,362,803 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Unexpected long-term survival in an adult patient with metastatic prostate cancer.
According to statistics, the 5-year overall survival in metastatic prostate cancer is about 21 months. We present a case of a patient with castration-resistant prostate cancer with proven bone lesions 2 years after the onset of the disea... | CYPROTERONE ACETATE, STRONTIUM, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33747795 | 19,362,803 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | ACYCLOVIR, ASPIRIN, CEFEPIME HYDROCHLORIDE, ENFORTUMAB VEDOTIN, LOSARTAN, METHYLPREDNISOLONE, MUPIROCIN, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33747934 | 19,970,496 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial fibrillation'. | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | ACYCLOVIR, ASPIRIN, CEFEPIME HYDROCHLORIDE, ENFORTUMAB VEDOTIN, LOSARTAN, METHYLPREDNISOLONE, MUPIROCIN, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33747934 | 19,970,496 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | DOCETAXEL | DrugsGivenReaction | CC BY | 33747934 | 19,967,042 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | ACYCLOVIR, ASPIRIN, CEFEPIME HYDROCHLORIDE, ENFORTUMAB VEDOTIN, LOSARTAN, METHYLPREDNISOLONE, MUPIROCIN, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33747934 | 19,970,496 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematuria'. | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | ASPIRIN, LOSARTAN, PEMBROLIZUMAB, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33747934 | 19,965,130 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | ACYCLOVIR, ASPIRIN, CEFEPIME HYDROCHLORIDE, ENFORTUMAB VEDOTIN, LOSARTAN, METHYLPREDNISOLONE, MUPIROCIN, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33747934 | 19,970,496 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyponatraemia'. | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | ACYCLOVIR, ASPIRIN, CEFEPIME HYDROCHLORIDE, ENFORTUMAB VEDOTIN, LOSARTAN, METHYLPREDNISOLONE, MUPIROCIN, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33747934 | 19,970,496 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | DOCETAXEL | DrugsGivenReaction | CC BY | 33747934 | 19,948,874 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic acidosis'. | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | ACYCLOVIR, ASPIRIN, CEFEPIME HYDROCHLORIDE, ENFORTUMAB VEDOTIN, LOSARTAN, METHYLPREDNISOLONE, MUPIROCIN, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33747934 | 19,970,496 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | DOCETAXEL | DrugsGivenReaction | CC BY | 33747934 | 19,948,874 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transitional cell carcinoma'. | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | DOCETAXEL | DrugsGivenReaction | CC BY | 33747934 | 19,948,874 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33747934 | 19,970,496 | 2021 |
What was the dosage of drug 'DOCETAXEL'? | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | UNK UNK, UNKNOWN | DrugDosageText | CC BY | 33747934 | 19,948,874 | 2021 |
What was the dosage of drug 'ENFORTUMAB VEDOTIN'? | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | 1.25 MILLIGRAM/KILOGRAM (ON DAYS 1 AND 8 OF CYCLE 1) | DrugDosageText | CC BY | 33747934 | 19,970,496 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | Fatal | ReactionOutcome | CC BY | 33747934 | 19,970,496 | 2021 |
What was the outcome of reaction 'Atrial fibrillation'? | Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction.
Enfortumab vedotin is a Nectin-4 directed antibody-drug conju... | Fatal | ReactionOutcome | CC BY | 33747934 | 19,970,496 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.